Edition:
United Kingdom

Fagron NV (FAGRO.BR)

FAGRO.BR on Brussels Stock Exchange

17.94EUR
4:35pm BST
Change (% chg)

€0.13 (+0.73%)
Prev Close
€17.81
Open
€17.75
Day's High
€17.97
Day's Low
€17.71
Volume
127,267
Avg. Vol
135,306
52-wk High
€17.97
52-wk Low
€13.43

About

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in... (more)

Overall

Beta: 1.50
Market Cap(Mil.): €1,279.54
Shares Outstanding(Mil.): 71.84
Dividend: 0.12
Yield (%): 0.47

Financials

  FAGRO.BR Industry Sector
P/E (TTM): 29.94 54.03 55.51
EPS (TTM): 0.59 -- --
ROI: 8.89 11.89 11.59
ROE: 22.14 13.19 16.33

Belgium's Fagron to expand into Mexico with Cedrosa buy

Belgian pharmaceutical ingredients group Fagron NV said on Monday it was acquiring Central de Drogas, S.A. de C.V. (Cedrosa) in a 352 million Mexican pesos ($18.39 million) cash deal to expand further its presence in Latin America.

13 May 2019

UPDATE 1-Belgium's Fagron to expand into Mexico with Cedrosa buy

May 13 Belgian pharmaceutical ingredients group Fagron NV said on Monday it was acquiring Central de Drogas, S.A. de C.V. (Cedrosa) in a 352 million Mexican pesos ($18.39 million) cash deal to expand further its presence in Latin America.

13 May 2019

Belgium's Fagron to expand into Mexico with Cedrosa buy

May 13 Belgian pharmaceutical ingredients group Fagron NV said on Monday it was acquiring Central de Drogas, S.A. de C.V. (Cedrosa) in a 352 million Mexican pesos ($18.39 million) cash deal to expand further its presence in Latin America.

13 May 2019

Earnings vs. Estimates